Life Sciences Technology
Parse Biosciences, a QIAGEN company headquartered in Seattle, Washington, is a global life sciences company that develops and commercializes single-cell sequencing technologies and related products for biomedical research. The company's product portfolio includes Evercode™ Whole Transcriptome, Evercode™ TCR, Gene Capture, and associated software solutions, which are utilized in more than 3,000 laboratories worldwide. Founded on technology developed at the University of Washington, Parse operates a 34,000-square-foot headquarters and laboratory facility in Seattle's South Lake Union district.
Beta · Sourced from candidate reports
Be the first to share your experience with Parse Biosciences.
Your reply helps other candidates know what to expect.
